A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Stanford University
OHSU Knight Cancer Institute
Children's Hospital of Philadelphia
University of Pennsylvania
University of Chicago
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AbbVie
OHSU Knight Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Novartis
Children's Oncology Group